Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

European Patient Summary

Patient
Name: Bertelsen, Bent
DOB: 12-SEP-1942 (Age: 83)
Gender: male
ID: 9943-935126-5 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 29-JUL-2025

Problem list

Condition Onset Date Status
Hyperlipidemia 2004-05-10 active
Essential hypertension 2001-04-23 active
Dependent drug abuse 1998-11-11 active
Chronic intractable migraine without aura 1990-06-19 active
Impacted molars 1990-04-13 active
Proliferative retinopathy due to type 2 diabetes mellitus 1985-07-08 active
Ischemic heart disease 1985-01-21 active
Macular edema and retinopathy due to type 2 diabetes mellitus 1971-11-08 active
Chronic sinusitis 1970-10-15 active
Nonproliferative retinopathy due to type 2 diabetes mellitus 1970-08-24 active
Retinopathy due to type 2 diabetes mellitus 1968-10-21 active
Anemia 1963-09-23 active
Metabolic syndrome X 1961-09-11 active
Hypertriglyceridemia 1960-09-05 active
Type 2 diabetes mellitus 1959-08-31 active

Medication list

Medication Since Form Dosage Reason
Simvastatin 10 mg oral tablet 2024-09-16 Oral tablet 1 tablet (10 mg) by mouth once daily Hyperlipidemia
Amlodipine (as amlodipine besylate) 2.5 mg oral tablet 2024-09-02 Oral tablet 1 tablet (2.5 mg) by mouth once daily Essential hypertension (disorder)
Lisinopril 10 mg oral tablet 2024-09-02 Oral tablet 1 tablet (10 mg) by mouth once daily Essential hypertension (disorder)
NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [ProAir] 2024-09-02 2 actuations (0.18 mg) every 4 to 6 hours as needed Childhood asthma
120 ACTUAT fluticasone propionate 0.11 MG/ACTUAT Metered Dose Inhaler [Flovent] 2024-09-02 2 actuations (220 mcg) twice daily Childhood asthma
Nitroglycerin 400 microgram/actuation sublingual spray 1985-01-28 Sublingual spray 400 micrograms (1 spray) under the tongue as needed for chest pain, may repeat every 5 minutes as needed, up to 3 sprays in 15 minutes
Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet 1985-01-28 Prolonged-release oral tablet 1 tablet (100 mg) once daily
ferrous sulfate 325 MG Oral Tablet 1963-10-01 1 tablet (325 mg) by mouth once daily
Vitamin B12 5 MG/ML Injectable Solution 1963-10-01 1 mL (5 mg) intramuscularly once monthly

Allergies and Intolerances

No known allergies or intolerances

Procedure History list

Procedure Date Reason
Pre-discharge assessment 2023-06-29 -
2023-06-29 -
Physical therapy procedure 2023-06-28 -
Nursing care/supplementary surveillance 2023-06-28 -
Professional / ancillary services care 2023-06-27 -
History AND physical examination 2023-06-26 -
Initial patient assessment 2023-06-26 -
Development of individualized plan of care 2023-06-26 -
Depression screening 2022-05-02 -
Medication reconciliation 2022-05-02 -
Assessment of health and social care needs 2022-05-02 -
Assessment of anxiety 2022-05-02 -
Assessment using Morse Fall Scale 2022-05-02 -
2022-05-02 -
Suture open wound 2017-05-27 Laceration of thigh

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 2024-09-02
SARS-CoV-2 mRNA vaccine 2021-05-03
Clostridium tetani toxoid antigen adsorbed only vaccine product 2019-08-05

Care Plan

Immunization Recommendation Due Date Reason
Vaccine product containing only Influenza virus antigen (medicinal product) 2025-10-01 Annual seasonal influenza vaccination

History of Past Illness

Condition Period Status
Drug overdose 2025-03-21 – 2025-03-22 inactive
Acute bronchitis 2022-05-16 – 2022-05-28 inactive
Acute viral pharyngitis 2022-04-11 – 2022-04-21 inactive
Acute viral pharyngitis 2020-11-27 – 2020-12-05 inactive
Drug overdose 2019-10-20 – 2019-10-21 inactive
Laceration of thigh 2017-05-27 – 2017-06-11 inactive
Laceration - injury 2017-05-27 – 2017-06-11 inactive
Drug overdose 2016-06-26 – 2016-06-26 inactive

Vital Signs

Vital Signs 2024-09-02 2023-08-28
Body Height 184.5 cm 184.5 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 1 {score} 2 {score}
Body Weight 92.2 kg 92.2 kg
Body mass index (BMI) [Ratio] 27.1 kg/m2 27.1 kg/m2
Diastolic Blood Pressure 63 mm[Hg] 60 mm[Hg]
Systolic Blood Pressure 115 mm[Hg] 115 mm[Hg]
Heart rate 91 /min 74 /min
Respiratory rate 14 /min 14 /min